Intradermal Injection Market

Intradermal Injection Market Outlook (2024 to 2034)

The global intradermal injection market is approximated to generate revenue worth US$ 3.22 billion in 2024 and has been thoroughly analyzed to expand at a noteworthy CAGR of 13% to achieve a value of US$ 10.93 billion by the end of 2034.

Intradermal injections are becoming more popular for immunization, allergy testing, and specific therapeutic interventions. Chronic diseases, such as diabetes, cancer, and autoimmune disorders are becoming more common worldwide and this factor is driving up demand for intradermal injections as more people need continuing care or preventive measures in such situations. When compared to other drug delivery methods, intradermal injections provide a less intrusive option with fewer side effects. This is especially appealing to people who choose less intrusive solutions for skin rejuvenation when it comes to cosmetic treatments such as Botox and dermal fillers. The efficiency and patient compliance of these new devices is increasing with the ongoing development of microneedle patches and precision delivery systems for intradermal injections. The market is expanding because of the advancements that make intradermal injections more widely available and simpler to use.

North America is evaluated to account for 37.2% portion of the worldwide intradermal injection market share in the current year (2024) because of its excellent healthcare system, high prevalence of chronic illnesses, and extensive immunization programs. Demand for intradermal injections is driven by the increasing presence in cosmetic operations including skin treatments and dermal fillers.

Based on the method, intradermal injections with normal-sized needles (mantoux) are projected to hold 43.3% of the revenue share in 2024 because of their extensive usage in diagnostic testing, especially for tuberculosis (TB) screening. Demand is consistently driven by the mantoux test, which employs needles of normal size and is the main method for diagnosing tuberculosis worldwide.

Report Attributes	Details
Intradermal Injection Market Size (2024E)	US$ 3.22 Billion
Forecasted Market Value (2034F)	US$ 10.93 Billion
Global Market Growth Rate (2024 to 2034)	13% CAGR
North America Market Share (2024E)	37.2%
East Asia Market Value (2024E)	US$ 541.05 Million
South Asia & Pacific Market Growth Rate (2024 to 2034)	15.4% CAGR
With Normal-sized Needles (Mantoux) Segment Value (2034F)	US$ 4.92 Billion
Tuberculin Skin Testing Segment Value (2034F)	US$ 6.49 Billion
Key Companies Profiled	BD (Becton, Dickinson, and Company); OraSure Technologies Inc.; AstraZeneca; Thermo Fisher Scientific; West Pharmaceutical Services, Inc.; Kyoto Kagaku Co. LTD.; Terumo Corporation; Sanofi; Roche Diagnostics; Bristol-Myers Squibb Company; Novartis; Eli Lilly and Company; Abbott Laboratories; Pfizer Inc.; Merck Group

Vaccines are administered through injections in the dermis, one of the layers of the skin. The dermis lies under the epidermis contains a large amount of immune cells, and is highly vascularized. Intradermal injections are one of the administration routes which is preferred for vaccination. There are 3 major routes: subcutaneous injections, intradermal injections, and intramuscular injections.

Each type of these administration routes targets a different skin layer, such as, intramuscular injections are administered into the muscle; subcutaneous injections are targeted onto the fat layer that lies under the skin; and intradermal injections are administered into the epidermis or dermis. Intradermal injections are administered by either devices specifically designed for intradermal injections or normal-sized needles with the use of the Mantoux technique.

In recent times, intradermal injections being delivered using the Mantoux technique have gained popularity. The Mantoux technique requires skilled professionals, as the needle has to be inserted inside the skin at approximately 5-15 degree angle. One of the alternatives available for intradermal injections is intradermal microinjections. For instance: VAX-ID, which is an intradermal device, offers advantages contradicting difficulties faced by the Mantoux technique.

Intradermal Injections Market: Drivers

Vaccination through intradermal injections has many advantages when compared to other vaccination types, like, a potential reduction of the antigen dose, an improved immune response to the vaccine, and decreased anxiety and pain post-vaccination.

These advantages over other vaccination types and the increase in healthcare expenditure are two of the primary factors boosting the demand for intradermal injections. Intradermal injections are also used for novel cancer and immunology treatments and faster drug uptake. The increasing incidence of diseases, including cancer, tuberculosis, and other allergies, is also expected to propel the market growth for intradermal injections during the forecast period. However, several side effects associated with intradermal injections include muscle pain, inflammations, malaise, and shivering, which might further restrain the market growth for intradermal injections during the forecast period.

Intradermal Injections Market: Overview

Intradermal injections are targeted on the upper back, inner surface of the forearm, and under the shoulder blade. Despite the advantages shown through various clinical studies, several barriers hinder the usage of intradermal injections. While Europe, the United States, and other developed countries rely on single-dose formats and have government funding or private insurance for vaccination, emerging markets are anticipated to favor multi-dose formats and are limited by availability and cost of supply.

Furthermore, the majority of the vaccines require cold chain distribution and storage, which further limits resources or refrigerator space in a healthcare setting. Globally, approximately 17.4 million people are prone to rabies through animal bites annually. It occurs in more than 150 territories and countries, rabies is a viral disease that causes encephalitis when transmitted to humans. Intradermal injections help to lower the cost of cell-derived vaccines for pre-exposure to rabies. The cost-savings with intradermal injections for rabies might create immense opportunities for the intradermal injections market during the forecast period.

Intradermal Injections Market: Regional Outlook

North America’s intradermal injections market is anticipated to grow the fastest during the forecast owing to the presence of local players in the market, and better and easy availability of intradermal injections in the region. Improvements in the healthcare infrastructure and government funding for intradermal injections are expected to create immense opportunities for intradermal injections in North America and Europe. Commercialization of various intradermal injections by the US.

FDA over the years has also been one of the primary factors fueling the demand for intradermal injections globally. Asia-Pacific’s market for intradermal injections is also expected to grow significantly during the forecast period due to improvements in healthcare expenditure, increasing investments by market players, and growing awareness of the advantages of intradermal injections.

Intradermal Injections Market: Key Players

Some of the major market participants operating in the global Intradermal Injections market are BD, OraSure Technologies Inc., West Pharmaceutical Services, Inc., Kyoto Kagaku Co. LTD., Terumo Corporation, Bristol-Myers Squibb Company, and others.

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Peru
  • Rest of LATAM
• Europe
  • EU - 4 (Germany, France, Italy, Spain)
  • UK
  • BENELUX (Belgium, Netherlands, Luxemburg)
  • NORDIC (Norway, Denmark, Iceland, Sweden)
  • Eastern Europe (Poland, Ukraine, Czech Rep., and Others)
  • Rest of Europe
• CIS & Russia
• Japan
• APEJ
  • Greater China
  • India
  • Korea
  • ASEAN Countries
  • Rest of APEJ
• Middle East & Africa
  • GCC Countries
  • Turkey
  • Iran
  • Israel
  • South Africa
  • Rest of MEA

Report Highlights

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Segmentation of Intradermal Injection Market Research

• By Methods :

  • With Normal-sized Needles (Mantoux)
  • With Short Needles
    • Intradermal Microinjection
    • Microneedle Arrays
    • Tattoo Devices
  • Without Needles
    • Intradermal Liquid Jet Injectors
    • Ballistic Intradermal Injectors

• By Application :

  • Tuberculin Skin Testing
  • Allergy Testing
  • Local Aesthetics

• By End User :

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa